Table 1.
Questions from IRB-Approved Key Informant Interview Guides.
Table 2.
Perceived Risks of HIV Cure Research from People Living with HIV (PLWHIV), n = 12, United States (2015–2016).
Table 3.
Summary of Perceived Risks of HIV Cure Research from Clinician/Biomedical Researchers, n = 11, United States (2015–2016).
Table 4.
Summary of Perceived Risks of HIV Cure Research from Policy-Makers/Bioethicists, n = 13, United States (2015–2016).
Table 5.
Perceived Unacceptable Risks in HIV Cure Research from Key Informants (People Living with HIV, Clinician-Researchers and Policy-Makers/Bioethicists, n = 36), United States (2015–2016).
Table 6.
Perceived Benefits of HIV Cure Research from Key Informants (People Living with HIV, Clinician-Researchers and Policy-Makers/Bioethicists, n = 36), United States (2015–2016).
Table 7.
Considerations Regarding Managing Risks and Benefits in HIV Cure Research.